Charles Schwab
HPTX

Charles Schwab’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Charles Schwab’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-295,901
Closed -$13.6M – 3207
2015
Q1 		$13.6M Buy
295,901
+20,592
+7% +$616K 0.02% 788
2014
Q4 		$6.61M Buy
275,309
+148,910
+118% +$3.36M 0.01% 1223
2014
Q3 		$3.19M Buy
126,399
+64,465
+104% +$1.6M 0.01% 1697
2014
Q2 		$1.62M Buy
61,934
+41,808
+208% +$1.07M ﹤0.01% 2090
2014
Q1 		$520K Buy
20,126
+420
+2% +$11.4K ﹤0.01% 2574
2013
Q4 		$399K Buy
19,706
+504
+3% +$11.9K ﹤0.01% 2670
2013
Q3 		$503K Buy
19,202
+679
+4% +$17K ﹤0.01% 2544
2013
Q2 		$408K Buy
+18,523
New +$406K ﹤0.01% 2600

Charles Schwab's HPTX Position: Q2 2015 in Review

Charles Schwab sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 295,901 shares — an estimated $13.6M sold.

Charles Schwab first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $13.6M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Charles Schwab reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Charles Schwab sold 295,901 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $13.6M.
  • Charles Schwab first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • Charles Schwab's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $13.6M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Charles Schwab's 13F filing for Q2 2015, filed 14 Aug 2015.